Small Molecules
2 February 2020
Positive CHMP opinion for darolutamide as a new treatment for men with non-metastatic castration-resistant prostate cancer31 January 2020
Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV)30 January 2020
Bayer application for nifurtimox to treat pediatric patients with Chagas disease submitted for approval in US30 January 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)28 January 2020
Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB260328 January 2020
Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients with Advanced Solid Tumors28 January 2020
Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis28 January 2020
US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports